Dyne Therapeutics (DYN) PT Raised to $35 at RBC Capital

July 30, 2026 8:33 AM

RBC Capital analyst Luca Issi raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $35.00 (from $30.00) while maintaining a Outperform rating.

No results found